First National Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.97M | Sell |
49,035
-3,066
| -6% | -$179K | 0.1% | 152 |
|
|
2025
Q4 | $2.81M | Sell |
52,101
-1,463
| -3% | -$70.4K | 0.09% | 159 |
|
|
2025
Q3 | $2.42M | Buy |
53,564
+15,742
| +42% | +$735K | 0.08% | 174 |
|
|
2025
Q2 | $1.75M | Sell |
37,822
-2,632
| -7% | -$129K | 0.07% | 192 |
|
|
2025
Q1 | $2.47M | Sell |
40,454
-14,756
| -27% | -$860K | 0.1% | 159 |
|
|
2024
Q4 | $3.12M | Sell |
55,210
-5,037
| -8% | -$281K | 0.12% | 139 |
|
|
2024
Q3 | $3.12M | Sell |
60,247
-6,035
| -9% | -$283K | 0.12% | 134 |
|
|
2024
Q2 | $2.75M | Sell |
66,282
-27,057
| -29% | -$1.21M | 0.11% | 138 |
|
|
2024
Q1 | $5.06M | Sell |
93,339
-119,168
| -56% | -$6.07M | 0.21% | 105 |
|
|
2023
Q4 | $10.9M | Sell |
212,507
-37,295
| -15% | -$1.96M | 0.48% | 59 |
|
|
2023
Q3 | $14.5M | Sell |
249,802
-67,816
| -21% | -$4.16M | 0.69% | 40 |
|
|
2023
Q2 | $20.3M | Buy |
317,618
+5,381
| +2% | +$361K | 0.94% | 25 |
|
|
2023
Q1 | $21.6M | Buy |
312,237
+2,260
| +0.7% | +$159K | 1.15% | 18 |
|
|
2022
Q4 | $22.3M | Buy |
309,977
+7,682
| +3% | +$579K | 1.18% | 19 |
|
|
2022
Q3 | $21.5M | Buy |
302,295
+5,004
| +2% | +$363K | 1.25% | 16 |
|
|
2022
Q2 | $22.9M | Buy |
297,291
+76,202
| +34% | +$5.8M | 1.29% | 16 |
|
|
2022
Q1 | $16.1M | Buy |
221,089
+37,709
| +21% | +$2.53M | 0.84% | 29 |
|
|
2021
Q4 | $11.4M | Buy |
183,380
+11,361
| +7% | +$666K | 0.6% | 49 |
|
|
2021
Q3 | $10.2M | Buy |
172,019
+3,765
| +2% | +$248K | 0.61% | 50 |
|
|
2021
Q2 | $11.2M | Sell |
168,254
-3,333
| -2% | -$217K | 0.68% | 42 |
|
|
2021
Q1 | $10.8M | Sell |
171,587
-13,379
| -7% | -$832K | 0.71% | 38 |
|
|
2020
Q4 | $11.5M | Buy |
184,966
+20,123
| +12% | +$1.24M | 0.79% | 36 |
|
|
2020
Q3 | $9.94M | Buy |
164,843
+9,717
| +6% | +$585K | 0.77% | 39 |
|
|
2020
Q2 | $9.12M | Buy |
155,126
+10,454
| +7% | +$625K | 0.77% | 39 |
|
|
2020
Q1 | $8.06M | Buy |
144,672
+7,418
| +5% | +$453K | 0.81% | 39 |
|
|
2019
Q4 | $8.81M | Buy |
137,254
+5,806
| +4% | +$333K | 0.72% | 42 |
|
|
2019
Q3 | $6.67M | Buy |
131,448
+7,909
| +6% | +$372K | 0.6% | 52 |
|
|
2019
Q2 | $5.6M | Buy |
123,539
+35,549
| +40% | +$1.66M | 0.52% | 56 |
|
|
2019
Q1 | $4.2M | Buy |
87,990
+34,902
| +66% | +$1.74M | 0.42% | 71 |
|
|
2018
Q4 | $2.76M | Sell |
53,088
-3,740
| -7% | -$201K | 0.31% | 95 |
|
|
2018
Q3 | $3.53M | Sell |
56,828
-3,975
| -7% | -$236K | 0.36% | 85 |
|
|
2018
Q2 | $3.37M | Sell |
60,803
-2,060
| -3% | -$111K | 0.37% | 84 |
|
|
2018
Q1 | $3.98M | Sell |
62,863
-3,113
| -5% | -$200K | 0.45% | 68 |
|
|
2017
Q4 | $4.04M | Sell |
65,976
-1,444
| -2% | -$90.3K | 0.44% | 67 |
|
|
2017
Q3 | $4.3M | Sell |
67,420
-389
| -0.6% | -$22.7K | 0.5% | 56 |
|
|
2017
Q2 | $3.78M | Buy |
67,809
+1,393
| +2% | +$75.8K | 0.46% | 61 |
|
|
2017
Q1 | $3.61M | Sell |
66,416
-2,420
| -4% | -$133K | 0.47% | 59 |
|
|
2016
Q4 | $4.02M | Sell |
68,836
-5,876
| -8% | -$321K | 0.57% | 46 |
|
|
2016
Q3 | $4.03M | Buy |
74,712
+3,521
| +5% | +$226K | 0.61% | 46 |
|
|
2016
Q2 | $5.24M | Sell |
71,191
-19,753
| -22% | -$1.4M | 0.8% | 34 |
|
|
2016
Q1 | $5.81M | Sell |
90,944
-2,257
| -2% | -$142K | 0.89% | 29 |
|
|
2015
Q4 | $6.41M | Sell |
93,201
-3,949
| -4% | -$261K | 1.01% | 24 |
|
|
2015
Q3 | $5.75M | Sell |
97,150
-4,365
| -4% | -$277K | 0.99% | 26 |
|
|
2015
Q2 | $6.75M | Sell |
101,515
-3,645
| -3% | -$240K | 1.09% | 23 |
|
|
2015
Q1 | $6.78M | Sell |
105,160
-10,555
| -9% | -$661K | 1.16% | 19 |
|
|
2014
Q4 | $6.83M | Sell |
115,715
-7,733
| -6% | -$436K | 1.22% | 17 |
|
|
2014
Q3 | $6.32M | Sell |
123,448
-25,431
| -17% | -$1.27M | 1.2% | 18 |
|
|
2014
Q2 | $7.22M | Buy |
148,879
+13,827
| +10% | +$681K | 1.39% | 11 |
|
|
2014
Q1 | $7.02M | Sell |
135,052
-1,741
| -1% | -$92.6K | 1.25% | 13 |
|
|
2013
Q4 | $7.27M | Sell |
136,793
-7,290
| -5% | -$371K | 1.32% | 12 |
|
|
2013
Q3 | $6.67M | Sell |
144,083
-1,952
| -1% | -$85.7K | 1.31% | 12 |
|
|
2013
Q2 | $6.53M | Buy |
+146,035
| New | +$6.34M | 1.34% | 12 |
|
Other funds holding BMY
VCM
VPM
First National Trust's BMY Position: Q1 2026 in Review
First National Trust reduced its Bristol-Myers Squibb (BMY) stake by 5.9% in Q1 2026, selling an estimated $179K and leaving 49,035 shares worth $2.97M. The position accounts for 0.1% of the portfolio, ranked #152.
First National Trust first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.9M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- First National Trust held 49,035 shares of Bristol-Myers Squibb worth $2.97M as of Q1 2026.
- First National Trust sold 3,066 Bristol-Myers Squibb shares in Q1 2026, an estimated $179K.
- Bristol-Myers Squibb made up 0.1% of First National Trust's portfolio in Q1 2026, its #152 holding.
- First National Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- First National Trust's Bristol-Myers Squibb position peaked at $22.9M in Q2 2022.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on First National Trust's 13F filing for Q1 2026, filed 7 May 2026.